铂类抗肿瘤药物的临床研究进展  

Clinical research advances on the Platinum anticancer drugs

作　　者：王少毕（综述）[1] 罗政（审校）[1] 

机构地区：[1]江西省人民医院肿瘤科,江西南昌330006

出　　处：《世界肿瘤杂志》2011年第1期9-11,16,共4页Tumour Journal of the World

摘　　要：铂类抗肿瘤药物是一类细胞周期非特异性抗肿瘤药物，自从Rosenberg首次观察到其能抑制细胞生长，人们对铂类配合物的研究就一直没有中断，期待发现疗效更高、适用范围更广、毒副作用更低、更经济的药物品种，至今仍不断有新的顺铂类配合物合成并应用于临床试验。该文在此对铂类抗肿瘤药物及其临床研究发展进行简要介绍。Platinum anticancer drugs are a class of cell cycle non-specific anticancer drugs, since the first time Rosenberg observed that the drugs could suppress cell growth, the research on the drugs kept on without interruption in order to find a new type of drug with higher efficacy, broader scope, lower toxicity, more economical. This article briefly reviewed the clinical research advances on the Platinum anticancer drugs.

关 键 词：铂类抗肿瘤药物 临床研究发展 

分 类 号：R730.53[医药卫生—肿瘤]